A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

書誌詳細
第一著者:	Ashraf, Anushey
その他の著者:	Khan, Tanisha Tabassum Sayka
フォーマット:	学位論文
言語:	English
出版事項:	Brac University 2023
主題:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
オンライン･アクセス:	http://hdl.handle.net/10361/19353

類似資料

Immunotherapy in the Management of Lung Cancer
著者:: Tasnim, Humayra
出版事項: (2022)

Potential of liposomes for the treatment of lung cancer- a review
著者:: Mim, Shanzida
出版事項: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
著者:: Tania, Umme
出版事項: (2023)

Molecules associated with the development of lung cancer
著者:: Rahman, Adree, 等
出版事項: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024)

A review on recent advances in drugs for lung cancer treatment
著者:: Noor, Fouzia
出版事項: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
著者:: Jeba, Joynob
出版事項: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
著者:: Razna, Amrin Islam
出版事項: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
著者:: Pial, Sazia Afrin
出版事項: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
著者:: Zangmo, Thinley
出版事項: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
著者:: Hoque, Ismoth Ara
出版事項: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
著者:: Shabnam, Musharrat
出版事項: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
著者:: Bristy, Israt Zerin
出版事項: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
著者:: Alam, Kazi Tasnuva
出版事項: (2022)

Lung cancer detection and classification using machine learning
著者:: Arefin, Mahbubul, 等
出版事項: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
著者:: Das, Reshita
出版事項: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
著者:: Jahan, Nusrat
出版事項: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
著者:: Nandy, Aditi
出版事項: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
著者:: Mukti, Roushney Fatima, 等
出版事項: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
著者:: Kamal, Tasnova
出版事項: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
著者:: Nahar, Kamrun
出版事項: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
著者:: Parvez, Safi
出版事項: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
著者:: Meem, Manila
出版事項: (2023)

A comprehensive review on drug repurposing in cancer treatment
著者:: Sarkar, Onusree
出版事項: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
著者:: Nashrah, Zannatul
出版事項: (2023)

Breast cancer therapy through Liposomal drug delivery system
著者:: Ome, Nusrat Jahan
出版事項: (2024)

Trend in approval of targeted biologics in the last two decades
著者:: Siddika, Khadiza
出版事項: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
著者:: Hasan, Amit
出版事項: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
著者:: Khondokar, Faiza
出版事項: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Karim, Samia Binte
出版事項: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
著者:: Alam, Tahera
出版事項: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
著者:: Abir, Shifaty Nur
出版事項: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
著者:: Rahman, Samia
出版事項: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
著者:: Islam, Saidul
出版事項: (2022)

The uses of bacteria in cancer therapy
著者:: Saha, Shimul, 等
出版事項: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
著者:: Chakraborty, Anuradha
出版事項: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
著者:: Tania, Umme
出版事項: (2021)